New Trends in Medicine Sciences, vol.5, no.2, pp.65-72, 2024 (Peer-Reviewed Journal)
Abstract: This study was conducted to investigate in pregnant
women after being infected with Severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) infection and whether any possible
complications develop for the pregnant woman and the baby. This
study was conducted on 301 pregnant women who were registered
and being followed up at the COVID-19 Home Follow-up and
Monitoring Coordination Centre. A questionnaire consisting of a
Personal Information Form questioning sociodemographic
characteristics and questions about the COVID-19 history of the
pregnant women during their pregnancies and information about the
baby after birth was administered to them by telephone. The mean
age of the pregnant women was 30.21±5.34 years and 79 (26.2%)
had received COVID-19 vaccine. Preeclampsia was observed in
1.0%, miscarriage in 5.8% and stillbirth in 0.3% of the pregnant
women. Two (0.7%) of the babies died after birth. 21.6% of the
babies had to be hospitalised due to a health problem. 2.3% of the
babies had COVID-19. 12.1% of the babies had respiratory distress
and 55.0% had jaundice (32.3% in the first 24 hours). Of the
jaundiced babies, 64 (41.3%) received treatment for jaundice. 13.9%
of the babies had breastfeeding problems after birth. Developmental
delay was found in 3.6% of the babies. There was no increase in the
risk of congenital anomalies and miscarriage rates due to COVID-19
in pregnant women, but the incidence of cardiac anomalies increased
compared to other anomalies. Abortion rates were higher in
vaccinated pregnant women compared to unvaccinated pregnant
women.